BDBM294009 (2S)-5-(1-(1H-Tetrazol-5- yl)pent-3-yn-2-yl)-2-((3-(4-(2- methoxyethoxy)-2- methylphenyl)benzo[b]thiophen- 5-yl)methoxy)pyridine::US10106553, Compound 41

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(-c4ccc(OCCOC)cc4C)c3c2)nc1

InChI Key InChIKey=QCGJYFSBJMZTRY-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 294009   

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 294009BDBM294009(US10106553, Compound 41 | (2S)-5-(1-(1H-Tetrazol-5...)
Affinity DataEC50:  19nMT: 2°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent